Understanding the complexities of Building-Integrated Agriculture. Can food shape the future built environment?

Our food system is facing an unprecedented challenge: feeding a fast growing population without depleting precious resources like energy, soil, and water.Furthermore, the increasing urbanization has rapidly exacerbated the gap between farm to plate, leaving cities vulnerable to changes in the production and supply chain, as demonstrated by recent pandemics and wars. In this context, emerging technologies that allow plants to grow in absence of soil, permit to produce food in high densely built-up areas, bringing food production right were most consumers live. These initiatives enter within the so called Building-Integrated Agriculture (BIA), which is referred as the practice of locating greenhouses and soilless plant cultivation technologies on top and inside mixed-use buildings to exploit the synergies between the building environment and agriculture, involving resource recovery such as water, energy and nutrient flows. This paper aims at determining strategies, objectives, and best practices of BIA projects through the review of 21 case studies, to understand how a new advanced and future-oriented agriculture applied within the cities borders, can possibly shape the urban built environment and food systems of the future

Environmental assessment of greenhouse herb production: A case of longitudinal improvement options in Sweden

The greenhouse sector has seen many advances to improve its resource demands, though little is known of the environmental impacts. This study aims to assess the environmental performance of a horticultural greenhouse in Sweden producing herbs. Life cycle assessment is employed to analyze different scenarios. These include previous measures, such as switching to organic fertilizers, a pellet burner, and reducing the packaging weight. Future scenarios are assessed, including increasing biofueled logistics, switching to LEDs, densifying production, and including recyclable packaging. The results suggest that GHG emissions were reduced by 32% per kg edible portion through past scenarios in current scenario. Additionally, densifying production and switching to LED lighting can lead to an additional 14% and 10% reduction in GHG emissions compared to the current system respectively, while also reducing other environmental impact categories. These results provide insights into the implications of environmental and resource improvement measures taken at greenhouses

Magnetic properties and spin dynamics in single molecule paramagnets Cu6Fe and Cu6Co

The magnetic properties and the spin dynamics of two molecular magnets have been investigated by magnetization and d.c. susceptibility measurements, Electron Paramagnetic Resonance (EPR) and proton Nuclear Magnetic Resonance (NMR) over a wide range of temperature (1.6-300K) at applied magnetic fields, H=0.5 and 1.5 Tesla. The two molecular magnets consist of CuII(saldmen)(H2O)}6{FeIII(CN)6}](ClO4)38H2O in short Cu6Fe and the analog compound with cobalt, Cu6Co. It is found that in Cu6Fe whose magnetic core is constituted by six Cu2+ ions and one Fe3+ ion all with s=1/2, a weak ferromagnetic interaction between Cu2+ moments through the central Fe3+ ion with J = 0.14 K is present, while in Cu6Co the Co3+ ion is diamagnetic and the weak interaction is antiferromagnetic with J = -1.12 K. The NMR spectra show the presence of non equivalent groups of protons with a measurable contact hyperfine interaction consistent with a small admixture of s-wave function with the d-function of the magnetic ion. The NMR relaxation results are explained in terms of a single ion (Cu2+, Fe3+, Co3+) uncorrelated spin dynamics with an almost temperature independent correlation time due to the weak magnetic exchange interaction. We conclude that the two molecular magnets studied here behave as single molecule paramagnets with a very weak intramolecular interaction, almost of the order of the dipolar intermolecular interaction. Thus they represent a new class of molecular magnets which differ from the single molecule magnets investigated up to now, where the intramolecular interaction is much larger than the intermolecular one

The SPOrt Project: Cosmological and Astrophysical Goals

We present the cosmological and astrophysical objectives of the SPOrt mission, which is scheduled for flying on the International Space Station (ISS) in the year 2002 with the purpose of measuring the diffuse sky polarized radiation in the microwave region. We discuss the problem of disentangling the cosmic background polarized signal from the Galactic foregrounds.Comment: 10 pages; 5 PS figures; requires aipproc2.cls, aipproc2.sty, epsfc.tex; to appear in Proc. of ``3K Cosmology'', Rome 5-10 Oct. 199

The effect of different bleaching protocols, used with and without sodium ascorbate, on bond strength between composite and enamel

This in vitro study aims to evaluate whether a solution of 10% sodium ascorbate (SA) may exert a beneficial effect on the bonding of composite to enamel after using different bleaching agents and protocols. Microtensile bond strength (μTBS) was evaluated on 72 freshly extracted human central incisors, divided into eight experimental groups and one control group (total n = 9): Group 1 serves as control (nonbleached). Group 2 was bleached with 5% carbamide peroxide. Group 3 was bleached with 5% carbamide peroxide and then treated with 10% SA. Group 4 was bleached with 10% carbamide peroxide. Group 5 was bleached with 10% carbamide peroxide, then treated with 10% SA. Group 6 was bleached with 16% carbamide peroxide. Group 7 was bleached with 16% carbamide peroxide, then treated with 10% SA. Group 8 was bleached with 6% hydrogen peroxide. Group 9 was bleached with 6% hydrogen peroxide, then treated with 10% SA. All groups were restored immediately after the different treatments using a resin composite. The μTBS values were measured using a universal testing machine and statistical analysis was performed by means of normality and variance analyses, SIDAK test for univariate test and multiple comparisons, and Student test to compare μTBS values of each group with the control. The mean μTBS values in groups 2, 4, 6, 8 were significantly lower than controls. For groups 3, 5, 7, 9, subjected to antioxidant (10% SA) application, all μTBS values increased significantly. However, only for Groups 3 and 5 there was no significant difference with the control. Applying 10% SA for 10 min may improve the bond strength composite/bleached enamel just when whitening is performed with 5% and 10% carbamide peroxide

Efeito do cultivo de espécies vegetais sobre a população de Pratylenchus brachyurus na soja.

O presente trabalho, conduzido em casa de vegetação da Embrapa Soja, em Londrina, PR, no período de novembro/2011 a março/2012, teve como objetivos principais conhecer a reação de 23 espécies vegetais a Pratylenchus brachyurus e avaliar a influência da incorporação de suas fitomassas (parte aérea e raízes) no solo sobre as população do nematoide e performance da soja semeada, na sequência, nos vasos. Os fatores de reprodução (FR) de P. brachyurus obtidos nas diferentes espécies vegetais avaliadas variaram de zero (Crotalaria spectabilis, crambe, guandu ‘Fava Larga’ e tremoço branco) a 4,8 (Lab- Lab ‘Rongai’). As espécies vegetais com FR mais altos, independente da quantidade/composição da fitomassa incorporada, resultaram sempre em populações do nematoide mais elevadas nas raízes da soja (‘CD 202’). De todas as espécies vegetais testadas, apenas as C. specetabilis (FR=zero) e C. ochroleuca (FR=0,3) reduziram de fato a população original (1.000 nematoides) de P. brachyurus no vaso

Number of comorbidities and their impact on perioperative outcome and costs - a single centre cohort study

AIMS OF THE STUDY: Multimorbidity is a growing global health problem, resulting in an increased perioperative risk for surgical patients. Data on both the prevalence of multimorbidity and its impact on perioperative outcome are limited. The American Society of Anesthesiologists (ASA) classification uses only the single most severe systemic disease to define the ASA class and ignores multimorbidity. This study aimed to assess the number and type of all anaesthesia-relevant comorbidities and to analyse their impact on outcome and hospital costs. METHODS: This cohort study is nested in the ClassIntra(R) validation study and includes only patients enrolled at the University Hospital of Basel. Approximately 30 patients per surgical discipline undergoing any type of in-hospital surgery were followed up until hospital discharge to record all intra- and postoperative adverse events. In addition, the type and severity of all perioperatively relevant comorbidities were extracted from the electronic medical record according to a predefined list. The primary endpoint was the number of all anaesthesia-relevant comorbidities by ASA class. Using structural equation models, the direct and indirect effects of comorbidities on costs were estimated after adjustment for the ASA class and further relevant confounders and mediators. RESULTS: Of 320 enrolled patients, 27 were ASA I (8%), 150 ASA II (47%), 116 ASA III (36%) and 27 ASA IV (8%). The median number of comorbidities per patient was 5 (range 0-18), this number significantly increasing with higher ASA class: 1 comorbidity (95% CI 0.0-2.0) in ASA I, 4 comorbidities (3.8-4.2) in ASA II, 9 (8.1-9.9) in ASA III and 12 (10-14) in ASA IV patients. Independent of ASA class, each additional comorbidity increased hospital costs by EUR 1,198 (95% CI 288-2108) with almost identical proportions of direct and indirect effects. The number of anaesthesia-relevant comorbidities also increased postoperative complications and postoperative length of hospital stay. CONCLUSIONS: Multimorbidity in perioperative patients is highly prevalent and has a relevant impact on hospital costs, independent of the ASA class. Incorporating multimorbidity into the ASA classification might be warranted to improve its predictive ability and support adequate reimbursement

The burden of visceral leishmaniasis in Italy from 1982 to 2012: a retrospective analysis of the multi-annual epidemic that occurred from 1989 to 2009

n/

Use of biological drugs in patients with psoriasis and psoriatic arthritis in italy: Results from the PSONG survey

This Italian multicenter retrospective study compared the drug survival and efficacy of differentanti-TNF agents in psoriasis (PsO) and psoriatic arthritis (PsA) patients. A database of PsO/PsApatients treated with adalimumab, etanercept, and infliximab from May 2013 to May 2014 wasanalyzed. PASI 75, 90, and 100 was calculated at each time point to evaluate efficacy. Drug sur-vival rate and probability of maintaining PASI response were evaluated. The impact of dependentvariables on probability of PASI 75 loss was evaluated by logistic regression. 1,235 patients wereincluded, 577 with PsO and 658 with PsA. Highest survival rates were observed with adalimumabfollowed by etanercept and infliximab in PsO and PsA patients. The probability of maintainingPASI response was significantly higher for adalimumab followed by infliximab. For PsO patients,the odds of losing PASI 75 was higher in etanercept-treated patients (OR: 8.1; 95% CI: 4.2–15.6,p<.001) or infliximab (OR: 6.6; 95% CI: 2.6–16.3,p<.001) vs. adalimumab. Likewise, for PsApatients the odds of losing PASI 75 was higher in etanercept-treated patients (OR: 2.3; 95% CI:1.4–3.8,p5.01) or infliximab (OR: 2.2; 95% CI: 1.1–4.1,p5.018) vs. adalimumab. Adalimumabcould be the best therapeutic option over other anti-TNF agents for the treatment of PsO and PsApatients

Quality of survival: a new concept framework to assess the quality of prolonged life in cancer

Background: Improved cancer care means that more patients are surviving longer, but there is a need to examine how well patients survive. We conducted an exploratory analysis of a new conceptual framework termed ‘quality of survival’ (QoS) that delineates the quality of patients’ experience. Methods: This project included an electronic database search to investigate the survivorship landscape and to create a visual QoS map and semi-structured interviews with patients (n = 35), clinicians (n = 40), and payers (n = 7) to support the QoS map. QoS was discussed in the context of two tumor types, metastatic non-small cell lung cancer and metastatic melanoma. Results: Despite increased long-term survival, no specific definition of QoS exists. Patients reported many impacts that affect QoS, clinicians viewed QoS as relevant to treatment decisions, and payers felt it could help communicate different aspects relevant to the patient. Four interconnected QoS dimensions were developed (quality of life, survival, side effects, and economic impact), which vary in importance along the care continuum. Conclusion: QoS is a patient-centric concept that could help decision-making and patient communication. The QoS map could provide a framework to monitor patient experience and help patients frame what treatment attribute is most important to them at any point in the cancer continuum